Therma Bright (TSE:THRM) has released an update.
Therma Bright Inc. has partnered with a new U.S. distributor to kick off sales of their Venowave device, targeting Medicare/Medicaid reimbursements. The initial success of the sales program could lead to the acquisition of inventory worth up to $2.38M. The company anticipates rapid sales and further orders, which is expected to significantly boost revenue and market valuation.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
